| First Author | Orengo JP | Year | 2018 |
| Journal | Dis Model Mech | Volume | 11 |
| Issue | 2 | PubMed ID | 29419414 |
| Mgi Jnum | J:257505 | Mgi Id | MGI:6118020 |
| Doi | 10.1242/dmm.032623 | Citation | Orengo JP, et al. (2018) Motor neuron degeneration correlates with respiratory dysfunction in SCA1. Dis Model Mech 11(2):dmm032623 |
| abstractText | Spinocerebellar ataxia type 1 (SCA1) is characterized by adult-onset cerebellar degeneration with attendant loss of motor coordination. Bulbar function is eventually impaired and patients typically die from an inability to clear the airway. We investigated whether motor neuron degeneration is at the root of bulbar dysfunction by studying SCA1 knock-in (Atxn1(154Q/+) ) mice. Spinal cord and brainstem motor neurons were assessed in Atxn1(154Q/+) mice at 1, 3 and 6 months of age. Specifically, we assessed breathing physiology, diaphragm histology and electromyography, and motor neuron histology and immunohistochemistry. Atxn1(154Q/+) mice show progressive neuromuscular respiratory abnormalities, neurogenic changes in the diaphragm, and motor neuron degeneration in the spinal cord and brainstem. Motor neuron degeneration is accompanied by reactive astrocytosis and accumulation of Atxn1 aggregates in the motor neuron nuclei. This observation correlates with previous findings in SCA1 patient tissue. Atxn1(154Q/+) mice develop bulbar dysfunction because of motor neuron degeneration. These findings confirm the Atxn1(154Q/+) line as a SCA1 model with face and construct validity for this understudied disease feature. Furthermore, this model is suitable for studying the pathogenic mechanism driving motor neuron degeneration in SCA1 and possibly other degenerative motor neuron diseases. From a clinical standpoint, the data indicate that pulmonary function testing and employment of non-invasive ventilator support could be beneficial in SCA1 patients. The physiological tests used in this study might serve as valuable biomarkers for future therapeutic interventions and clinical trials.This article has an associated First Person interview with the first author of the paper. |
